The Venture Codex Logo

The Venture Codex

UCB Ventures

Allée de la Recherche 60, Brussels, Bruxelles Capitale, 1070, Belgium

Overview

Strategic corporate venture fund investing €150 million.

Founded

2017

Deals · 12mo

0

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series A
Series B

Geographic focus

Belgium
Spain
United States

Sector focus

—

Investment portfolio

25rounds
NAMEDATESIZE
Splice Bio
Jun 2025Participated
$135 MSeries B
Neurava
Apr 2024Participated
$2 MSeed
Neurona Therapeutics
Feb 2024Participated
$120 MOther Equity
ViaNautis
Nov 2023Led
$25 MSeries A
Switch Therapeutics
Mar 2023Led
$52 MSeries A
Code Biotherapeutics
Jun 2022Participated
$75 MSeries A
Splice Bio
Feb 2022Led
$57 MSeries A
Neurona Therapeutics
Jun 2021Led
$42 MOther Equity
ExeVir Bio
May 2021Participated
$50 MSeries A
Rinri Therapeutics
Apr 2021Participated
$14 MOther Equity
StrideBio
Mar 2021Participated
$82 MSeries B
Locanabio
Dec 2020Participated
$100 MSeries B
Splice Bio
Jun 2025Participated
$135 MSeries B
Neurava
Apr 2024Participated
$2 MSeed
Neurona Therapeutics
Feb 2024Participated
$120 MOther Equity
ViaNautis
Nov 2023Led
$25 MSeries A
Switch Therapeutics
Mar 2023Led
$52 MSeries A
Code Biotherapeutics
Jun 2022Participated
$75 MSeries A
Splice Bio
Feb 2022Led
$57 MSeries A
Neurona Therapeutics
Jun 2021Led
$42 MOther Equity
ExeVir Bio
May 2021Participated
$50 MSeries A
Rinri Therapeutics
Apr 2021Participated
$14 MOther Equity
StrideBio
Mar 2021Participated
$82 MSeries B
Locanabio
Dec 2020Participated
$100 MSeries B
25
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

UCB Ventures: 25 funding rounds are recorded in the selected participation categories.All available history.
UCB Ventures: 25 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed11
Series A44
Series B17
Series C+11
Other Equity13
Debt01

Monthly Deal Activity

UCB Ventures: 25 deals are recorded across 193 months.All available history.
UCB Ventures: 25 deals are recorded across 193 months. All available history
MonthDeals
Oct '101
Nov '100
Dec '100
Jan '110
Feb '110
Mar '110
Apr '110
May '110
Jun '110
Jul '110
Aug '110
Sep '110
Oct '110
Nov '110
Dec '110
Jan '120
Feb '120
Mar '120
Apr '120
May '120
Jun '120
Jul '120
Aug '120
Sep '120
Oct '120
Nov '120
Dec '120
Jan '130
Feb '130
Mar '130
Apr '130
May '130
Jun '130
Jul '130
Aug '130
Sep '130
Oct '130
Nov '130
Dec '130
Jan '140
Feb '140
Mar '140
Apr '140
May '140
Jun '140
Jul '140
Aug '141
Sep '140
Oct '140
Nov '140
Dec '140
Jan '150
Feb '150
Mar '150
Apr '150
May '150
Jun '151
Jul '150
Aug '150
Sep '150
Oct '150
Nov '150
Dec '150
Jan '160
Feb '160
Mar '160
Apr '161
May '160
Jun '160
Jul '160
Aug '160
Sep '160
Oct '160
Nov '160
Dec '160
Jan '170
Feb '170
Mar '170
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '181
Jul '180
Aug '180
Sep '181
Oct '180
Nov '180
Dec '180
Jan '190
Feb '191
Mar '190
Apr '190
May '192
Jun '190
Jul '190
Aug '191
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '201
Aug '201
Sep '200
Oct '201
Nov '200
Dec '201
Jan '210
Feb '210
Mar '211
Apr '211
May '211
Jun '211
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '221
Mar '220
Apr '220
May '220
Jun '221
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '231
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '231
Dec '230
Jan '240
Feb '241
Mar '240
Apr '241
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '251
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

UCB Ventures: Health & Life Sciences is the largest displayed sector by deal count (24 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

UCB Ventures: Health & Life Sciences is the largest displayed sector by deal count (24 deals). All available history
SectorDeals
Health & Life Sciences24
Data, Analytics & IT2
Networks, Cloud & Communication1

Deal Size Distribution

UCB Ventures: 25 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

UCB Ventures: 25 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M1
$10M-$25M3
$25M-$50M7
$50M-$100M9
$100M-$250M3
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

UCB Ventures: United States has the largest recorded deal count among the displayed regions (16 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

UCB Ventures: United States has the largest recorded deal count among the displayed regions (16 deals). All available history
RegionDeals
United States16
Europe8
Canada1
UCB Ventures: 20 co-investors are shown, with New Enterprise Associates sharing 8 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

UCB Ventures: 20 co-investors are shown, with New Enterprise Associates sharing 8 recorded deals. All available history
Co-investorShared deals
New Enterprise Associates8
Alexandria Venture Investments4
Amgen Ventures3
ARCH Venture Partners3
Hatteras Venture Partners3
Takeda Ventures3
Ysios Capital3
4BIO Capital2
Asabys Partners2
BioCity2
Boehringer Ingelheim2
Eli Lilly and Company2
Flare Capital Partners2
Fund+2
Gilde Healthcare2
Google Ventures2
Horizon Health Services2
Lakestar2
Lightstone Ventures2
McKesson Ventures2

Investment Strategy

UCB Ventures: Led accounts for 32% and participating for 68% of round participation.All available history.
UCB Ventures: Led accounts for 32% and participating for 68% of round participation. All available history
CategoryDeals (count)Share (%)
Led832%
Participating1768%
UCB Ventures: Single-lead accounts for 25% and co-led for 75% of lead dynamics.All available history.
UCB Ventures: Single-lead accounts for 25% and co-led for 75% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead225%
Co-led675%

Team

Alicia Iruzun Lafitte

Partner

Delphine Hajaji

Partner

Emmanuel Lacroix

Partner

Erica Whittaker

Head of UCB Ventures

Joshua Sands

Principal

Steven Biesmans

Executive